Rhythm Pharmaceuticals
The Executive Director, Regulatory CMC leads an integrated group of regulatory CMC professionals and owns the regulatory CMC product portfolio strategy as a member of the Regulatory Affairs Leadership Team. This role partners with functional heads to ensure the timely delivery of science-based Quality documentation for the company's portfolio from development through post-approval. The position serves as the senior strategic leader for regulatory CMC, providing enterprise-level leadership and guiding science-based, pragmatic strategies and risk-based decisions across the portfolio.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Senior Director, Regulatory Affairs CMC – Biologics
Beeline Medicines
Senior Director, Regulatory Affairs CMC – Small Molecules
Beeline Medicines
Senior Regulatory CMC Strategist (Senior Director)
C0003153479P
Senior Regulatory CMC Strategist (Senior Director)
C0003153479P
Associate Director, CMC Regulatory Affairs
Travere Therapeutics
GRA CMC Lead
sanofi us